# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Lymphomatoid papulosis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-6 of 6 results.
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
Status: Recruiting
Last Changed: Oct 06, 2020
First Received: Jul 16, 2018
Disease(s): Mycosis Fungoides, Lymphomatoid Papulosis, Sezary Syndrome
Intervention(s): brentuximab vedotin, brentuximab vedotin, brentuximab vedotin
Locations: Stanford University Medical Center, Stanford, California, United States
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Memorial Sloan Kettering Commack, Commack, New York, United States
... and 4 other locations.
SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
Status: Active, not recruiting
Last Changed: Nov 25, 2020
First Received: May 12, 2011
Disease(s): CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma, Lymphoma, Primary Cutaneous Anaplastic Large Cell, Lymphomatoid Papulosis, Mycosis Fungoides, Skin Lymphoma, Cutaneous Lymphomas, Lymphoma, Hematologic Disorder
Intervention(s): SGN-35
Locations: University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Tissue Repository: CTCL Collection Protocol
Status: Recruiting
Last Changed: Jan 22, 2020
First Received: Jul 21, 2016
Disease(s): Lymphoma, T-Cell, Cutaneous, Lymphomatoid Papulosis, Sézary Syndrome
Locations: Columbia University Medical Center, New York, New York, United States
Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma
Status: Completed
Last Changed: Dec 18, 2014
First Received: Dec 10, 2004
Disease(s): Large Cell Lymphoma
Intervention(s): SGN-30
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
University of California at Los Angeles, Los Angeles, California, United States
Stanford University, Stanford, California, United States
Yale, New Haven, Connecticut, United States
Northwestern Universtiy, Chicago, Illinois, United States
... and 9 other locations.
Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma
Status: Recruiting
Last Changed: Mar 03, 2020
First Received: Jan 24, 2018
Disease(s): Lymphomatoid Papulosis, Primary Cutaneous Anaplastic Large Cell Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma, Stage II Cutaneous T-Cell Non-Hodgkin Lymphoma, Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma, Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma
Intervention(s): Brentuximab Vedotin, Laboratory Biomarker Analysis, Lenalidomide
Locations: Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
Status: Recruiting
Last Changed: Apr 30, 2020
First Received: Jul 26, 2018
Disease(s): Lymphoma, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Cutaneous Lymphoma, Cutaneous Anaplastic Large Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphomatoid Papulosis, Cutaneous T Cell Lymphoma, Gray Zone Lymphoma
Intervention(s): ATLCAR.CD30.CCR4 cells, ALTCAR.CD30 cells, Bendamustine, Fludarabine
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States